As mentioned previously, MPN is thought to result from hyperactivation of the JAK/STAT signalling pathway through mutations in driver genes such as JAK2V617F, CALR, and MPL [29]. The gene discussed is SOAT1; the disease is myeloproliferative neoplasm.